Abstract
Thomas Hope, an associate professor in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco, spoke with Josh Mailman, an internationally recognized advocate for neuroendocrine tumor patients as well as an advocate for nuclear medicine and molecular
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have